QbD development of a liposomal co-formulation with Doxorubicin and Simvastatin for an enhanced antiproliferative effect on T47D-KBluc cell line
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI